Azenta (AZTA) Cash & Current Investments (2010 - 2026)
Azenta (AZTA) recorded quarterly Cash & Current Investments of $380.5 million in Q1 2026, up 12.24% quarter-over-quarter from $339.0 million in Q4 2025, and up 48.79% on a YoY basis from $255.7 million in Q1 2025.
Azenta (AZTA) Cash & Current Investments (2010 - 2026) Analysis & Trends
Azenta's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $380.5 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 48.79% year-over-year to $380.5 million; the TTM figure through Mar 2026 stood at $380.5 million (up 48.79% YoY), while the FY2025 annual figure was $339.0 million, changed N/A from the prior year.
- Cash & Current Investments was $380.5 million for Q1 2026 at Azenta, up from $339.0 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $2.8 billion in Q1 2022 to a low of $255.7 million in Q1 2025.
- Historically, Cash & Current Investments has averaged $752.6 million across 5 years, with a median of $380.5 million in 2026.
- The sharpest annual moves came in 2022 and 2024: Cash & Current Investments jumped 759.7% in 2022, then slumped 70.04% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $656.3 million in 2022, then grew by 7.84% to $707.7 million in 2023, then slumped by 46.37% to $379.6 million in 2024, then fell by 10.68% to $339.0 million in 2025, then advanced by 12.24% to $380.5 million in 2026.
- The last three Cash & Current Investments figures came in at $380.5 million (Q1 2026), $339.0 million (Q4 2025), and $282.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 4.52 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.02 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.24 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.66 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 521.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.06 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.02 Bn |
| 10 | Azenta | 1.06 Bn | 682.62 Mn | 62.04 Mn | 380.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 380.52 Mn |
| Dec 31, 2025 | 339.02 Mn |
| Sep 30, 2025 | 282.14 Mn |
| Jun 30, 2025 | 272.35 Mn |
| Mar 31, 2025 | 255.74 Mn |
| Dec 31, 2024 | 379.57 Mn |
| Sep 30, 2024 | 282.10 Mn |
| Jun 30, 2024 | 337.38 Mn |
| Mar 31, 2024 | 353.84 Mn |
| Dec 31, 2023 | 707.72 Mn |
| Sep 30, 2023 | 654.13 Mn |
| Jun 30, 2023 | 735.66 Mn |
| Mar 31, 2023 | 1.18 Bn |
| Dec 31, 2022 | 656.26 Mn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 2.18 Bn |
| Mar 31, 2022 | 2.75 Bn |
| Dec 31, 2021 | 215.22 Mn |
| Sep 30, 2021 | 234.57 Mn |
| Jun 30, 2021 | 269.96 Mn |